Title:
腫瘍を標的としたＩＬ−２バリアント免疫サイトカインとヒトＰＤ−Ｌ１に対する抗体との併用療法
Document Type and Number:
Japanese Patent JP6594573
Kind Code:
B2
Abstract:
The present invention relates to the combination therapy of specific tumor-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1.
Inventors:
Umagna, Pablo
Klein, Christian
Nicolini, Valeria F.
Klein, Christian
Nicolini, Valeria F.
Application Number:
JP2019024360A
Publication Date:
October 23, 2019
Filing Date:
February 14, 2019
Export Citation:
Assignee:
Ef Hoffman-La Roche Akchengezel Shaft
International Classes:
C07K16/30; A61K38/20; A61K39/395; A61P43/00; C07K14/55
Domestic Patent References:
| JP2014519807A | ||||
| JP2012511329A | ||||
| JP2014509857A | ||||
| JP2014506793A |
Attorney, Agent or Firm:
Sonoda/Kobayashi Patent Business Corporation